News
Makers of blood-pressure medication expand their recall The recall of Losartan is linked to a possible cancer-causing element known as NMBA.
Since July 2018, there have been a string of recalls related to three common generic heart drugs — losartan, irbesartan and valsartan — due to the detection of probable human carcinogens.
Mylan Pharmaceuticals has recalled three common blood pressure medications over concerns they could include small amounts of a cancer-causing impurity.
Interestingly, a recent study comparing dual fixed-dose combinations of losartan/hydrochlorothiazide and losartan/amlodipine in Japanese subjects with uncontrolled hypertension found that losartan ...
AurobindoPharma USA has expanded its recall of valsartan and amlodipine and valsartan tablets to 38 additional lots after the impurity called N-nitrosodiethylamine was found in the medications.
Find out how to take Amlodipine and Losartan(drug) and its dose. Describes the best time to take the drug and precautions if any that should be followed.
Cite this: A Comparative Evaluation of Amlodipine and Hydrochlorothiazide as Monotherapy in the Treatment of Isolated Systolic Hypertension in the Elderly - Medscape - May 01, 2000.
Discover comprehensive details about Amlodipine and Losartan, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The ...
Last week, the FDA alerted patients and health care professionals to a voluntary recall of one lot of losartan potassium/hydrochlorothiazide (HCTZ) 100mg/25mg combination tablets manufactured by ...
This particular version of the pill, which Wald holds the patent for in Europe and Canada, is made up of the blood pressure drugs amlodipine, losartan and hydrochlorothiazide and a cholesterol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results